Retrophin no more: Shkreli's legacy disappears as former company becomes Travere Therapeutics

Retrophin no more: Shkreli's legacy disappears as former company becomes Travere Therapeutics

Source: 
Endpoints
snippet: 

Retrophin is shedding the last of its ties to convicted “Pharma Bro” Martin Shkreli and his failed neurological drug — with a name change.